Matthew Scott Harris
Chief Medical Officer · Altimmune, Inc.
Individual
- 2025
- Jul 31, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew Scott Harris files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jerome Benedict Durso - $162K in ALT purchases and sales in the last 12 months
- Gregory L. Weaver - $49K in ALT purchases and sales in the last 12 months
- John Gill - $31K in ALT purchases and sales in the last 12 months
- Wayne Pisano - $20K in ALT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew Scott Harris?
Matthew Scott Harris is a corporate insider, tracked as Chief Medical Officer of Altimmune, Inc. (ALT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Matthew Scott Harris last file a Form 4?
The only primary Form 4 on record is dated 31 July 2025.
